ArticleFrontiers in public health2025
The paradox of better population health after the pandemic: what is the cause?
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to verify the hypothesis that the improvement in the subjective assessment of population health in certain European countries after the COVID-19 pandemic was driven by the mortality of the majority of vulnerable citizens with the worst health status. Methods: We extended the trend of the share of the oldest age group and compared it with the observed fraction, thereby identifying the "missing population." Results: We observed a substantial deficit in the population of the oldest age group, especially in countries where people tend not to age well. Conclusion: The temporary improvement in population health indicators, as measured by Healthy Life Years (HLY), during the pandemic in some countries was most likely an artifact resulting from the mortality of the majority of vulnerable individuals with poor health status. It is unlikely that this apparent improvement reflects healthier lifestyles or genuine gains in the efficiency or resilience of health systems during the pandemic. Therefore, the interpretation and use of HLY values from the COVID-19 period in Europe should be carefully reconsidered and further validated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.